Medical Condition News

RSS

New computer chip models how neurons communicate with each other at synapses

For decades, scientists have dreamed of building computer systems that could replicate the human brain's talent for learning new tasks. MIT researchers have now taken a major step toward that goal by designing a computer chip that mimics how the brain's neurons adapt in response to new information. This phenomenon, known as plasticity, is believed to underlie many brain functions, including learning and memory.

16 Nov 2011

Scientists discover definitive role for brain in regulating loss of muscle mass

Patients with cancer, heart disease and other chronic illness struggle not only with complications inherent to their disease, they also experience an involuntary loss of weight and muscle mass triggered by the body's natural response to infection and inflammation. Increasing nutrition intake does not mitigate the process and there is no treatment.

16 Nov 2011

Silibinin stops spread of lung cancer in mice

Tissue with wound-like conditions allows tumors to grow and spread. In mouse lung cancer cells, treatment with silibinin, a major component of milk thistle, removed the molecular billboards that signal these wound-like conditions and so stopped the spread of these lung cancers, according to a recent study published in the journal Molecular Carcinogenesis.

16 Nov 2011

Specific gene variant may increase risk of premature death in people with alcohol dependency

People who are alcohol-dependent and who also carry a particular variant of a gene run an increased risk of premature death. This is a recent finding from the interdisciplinary research at the Department of Psychology and the Sahlgrenska Academy at the University of Gothenburg, Sweden.

15 Nov 2011

EPO-secreting engineered vessels could reverse anemia

Patients who rely on recombinant, protein-based drugs must often endure frequent injections, often several times a week, or intravenous therapy. Researchers at Children's Hospital Boston demonstrate the possibility that blood vessels, made from genetically engineered cells, could secrete the drug on demand directly into the bloodstream.

15 Nov 2011

Alnylam announces new data from ALN-TTR01 Phase I trial on TTR-mediated amyloidosis

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it will present new data from its ALN-TTR program at the VIIIth International Symposium on Familial Amyloidotic Polyneuropathy being held in Kumamoto, Japan from November 20-22, 2011.

15 Nov 2011

Exercise may help fibromyalgia: Study

A new study shows that fibromyalgia patients who stopped taking medication but exercised regularly for six weeks reported improved memory function and less pain. While the finding is encouraging, it does not suggest a potential change in clinical care for fibromyalgia patients, the study authors stressed.

15 Nov 2011

Ellipse MAGEC System wins 2011 Best New Technology in Spine Care Award

Ellipse Technologies, Inc. today announced the Company's unique MAGEC Remote Control Spinal Deformity System has been awarded the 2011 Best New Technology in Spine Care Award.

15 Nov 2011

Moberg Derma receives Vinnova grant to develop Limtop for actinic keratosis, genital warts

Moberg Derma AB has been granted 4 MSEK by Vinnova for the development of Limtop, an innovative formulation for the treatment of actinic keratosis, genital warts and basal cell cancer.

15 Nov 2011

Midatech receives Swissmedic approval to start trial of insulin-coated gold nanoparticle

Midatech Ltd., a global leader in the design, development, synthesis and manufacture of nanomedicines, announced today it has received Swissmedic approval to start the First-in-Human clinical trial with insulin-coated gold nanoparticles, which will be coordinated through its Swiss subsidiary PharMida AG.

15 Nov 2011

Scil Proteins completes manufacturing agreement with Lundbeck

Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today the successful completion of a manufacturing agreement for Lundbeck, an international pharmaceutical company specializing in central nervous system disorders.

15 Nov 2011

Long-term AED therapy may increase risk of atherosclerosis in epilepsy patients

New research reveals that patients with epilepsy who were treated for extended periods with older generation antiepileptic drugs (AEDs) may be at increased risk for developing atherosclerosis, a common disorder known as hardening of the arteries.

15 Nov 2011

Positive long-term data from Abbott's ABSORB drug eluting BVS trial on CAD

Abbott today announced positive long-term data from the two-stage ABSORB trial, which is evaluating the ABSORB drug eluting bioresorbable vascular scaffold (BVS) for the treatment of coronary artery disease.

15 Nov 2011

Tigecycline antibiotic shows promise against leukemia

Clinician-scientists in the Princess Margaret Cancer Program have found a promising approach to treating leukemia, using an old drug in a new way.

15 Nov 2011

Stem cell therapy within 2 or 3 weeks does not improve heart function after attack

A research network led by a Mayo Clinic physician found that stem cells obtained from bone marrow delivered two to three weeks after a person has a heart attack did not improve heart function.

15 Nov 2011

POZEN reports positive Phase 1 study results comparing PA32540 to clopidogrel for CVDs

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, presented positive results today from a Phase 1 study comparing a dose-timing strategy of PA32540 and clopidogrel spaced 10 hours apart as compared to synchronous administration of enteric-coated (EC) omeprazole (40 mg), enteric-coated aspirin (81 mg) and clopidogrel.

15 Nov 2011

Stem cell injections within two weeks may not help in post heart attack recovery

University Hospitals Case Medical Center researchers could still be close to giving heart attack patients a second chance-just not as they originally thought.

15 Nov 2011

Study identifies demographic and health related characteristics related to mobility limitation

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health and featured in a 2011 issue of the Journal of Gerontology, has identified demographic and health related characteristics that were related to mobility limitation.

15 Nov 2011

Delay in hypothermia, ROSC linked with poor post cardiac arrest neurologic outcomes

Delay in initiation of therapeutic hypothermia and delay in return of spontaneous circulation (ROSC), evidenced by a palpable pulse or a measurable blood pressure, were both associated with poor neurologic outcomes in post cardiac arrest patients, according to a study being presented Nov. 14 at the at the American Heart Association (AHA) scientific sessions in Orlando, Fla.

15 Nov 2011

Head hits appear to cause brain injury among high school players

The brain scans of high school football and hockey players showed subtle injury -- even if they did not suffer a concussion - after taking routine hits to the head during the normal course of play, according to a University of Rochester Medical Center study.

15 Nov 2011

Medical Condition News

New computer chip models how neurons communicate with each other at synapses

Scientists discover definitive role for brain in regulating loss of muscle mass

Silibinin stops spread of lung cancer in mice

Specific gene variant may increase risk of premature death in people with alcohol dependency

EPO-secreting engineered vessels could reverse anemia

Alnylam announces new data from ALN-TTR01 Phase I trial on TTR-mediated amyloidosis

Exercise may help fibromyalgia: Study

Ellipse MAGEC System wins 2011 Best New Technology in Spine Care Award

Moberg Derma receives Vinnova grant to develop Limtop for actinic keratosis, genital warts

Midatech receives Swissmedic approval to start trial of insulin-coated gold nanoparticle

Scil Proteins completes manufacturing agreement with Lundbeck

Long-term AED therapy may increase risk of atherosclerosis in epilepsy patients

Positive long-term data from Abbott's ABSORB drug eluting BVS trial on CAD

Tigecycline antibiotic shows promise against leukemia

Stem cell therapy within 2 or 3 weeks does not improve heart function after attack

POZEN reports positive Phase 1 study results comparing PA32540 to clopidogrel for CVDs

Stem cell injections within two weeks may not help in post heart attack recovery

Study identifies demographic and health related characteristics related to mobility limitation

Delay in hypothermia, ROSC linked with poor post cardiac arrest neurologic outcomes

Head hits appear to cause brain injury among high school players

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News